Photobiomodulation Equipment and Training - THOR Photomedicine

Select Region

Information contained on this page may not be appropriate for your region, please select your region from below. To navigate back to this region selector, please click "Region" in the footer.
Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

THOR Photobiomodulation for Wound Healing

"It is simple to use, very cost-effective in terms of finance and time, and comes in its own case for easy transport between patients. It is used in conjunction with the patient's dressing regime"
See the full article by Tissue Viability Nurse, Lydia Jack

See the Treatment Video »

"Nurses who treat wounds should have access to PBM equipment. It would be a cost effective method of improving the quality of life of many patients"
See the full article by biologist Dr Mary Dyson

Raymond Lanzafame "Our preliminary experience has been overwhelmingly positive. The THOR DD II device is very simple to use and calibrate and is quite predictable in its function and effect. Wounds are healing more rapidly than, we have noted, in work with other devices..., although the wounds are indeed healing with PBM applied using the appropriate parameters/dosimetry. It is our belief that these devices are an important adjunct. My personal bias would be to apply this technology to patients early; that is, to treat them at the first sign of a wound or injury. We are continuing our clinical and laboratory investigations aimed at elucidating the mechanisms and utility of photobiomodulation in humans."

Treatment Video


Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates